250. Balch C. M., Soong S. J., Smith T., Ross M. I., Urist M. M., Karakousis C. P., Temple W. J., Mihm M. C., Barnhill R. L., Jewell W. R., Wanebo H. J., Desmond R., Investigators from the Intergroup Melanoma Surgical T. Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas // Ann Surg Oncol. ‒ 2001. ‒ T. 8, № 2. ‒ C. 101-8.
251. Felton S., Taylor R. S., Srivastava D. Excision Margins for Melanoma In Situ on the Head and Neck // Dermatol Surg. ‒ 2016. ‒ T. 42, № 3. ‒ C. 327-34.
252. Rawlani R., Rawlani V., Qureshi H. A., Kim J. Y., Wayne J. D. Reducing margins of wide local excision in head and neck melanoma for function and cosmesis: 5-year local recurrence-free survival // J Surg Oncol. ‒ 2015. ‒ T. 111, № 7. ‒ C. 795-9.
253. Moehrle M., Metzger S., Schippert W., Garbe C., Rassner G., Breuninger H. "Functional" surgery in subungual melanoma // Dermatol Surg. ‒ 2003. ‒ T. 29, № 4. ‒ C. 366-74.
254. Pockaj B. A., Jaroszewski D. E., DiCaudo D. J., Hentz J. G., Buchel E. W., Gray R. J., Markovic S. N., Bite U. Changing surgical therapy for melanoma of the external ear // Ann Surg Oncol. ‒ 2003. ‒ T. 10, № 6. ‒ C. 689-96.
255. Christie D. R., Tiver K. V. Radiotherapy for melanotic freckles // Austral Radiol. ‒ 1996. ‒ T. 40. ‒ C. 331-333.
256. Strom T., Caudell J. J., Han D., Zager J. S., Yu D., Cruse C. W., Marzban S. S., Messina J. L., Trotti A. M., Sondak V. K., Rao N. G. Radiotherapy influences local control in patients with desmoplastic melanoma // Cancer. ‒ 2014. ‒ T. 120, № 9. ‒ C. 1369-78.
257. Chang D. T., Amdur R. J., Morris C. G., Mendenhall W. M. Adjuvant radiotherapy for cutaneous melanoma: comparing hypofractionation to conventional fractionation // Int J Radiat Oncol Biol Phys. ‒ 2006. ‒ T. 66, № 4. ‒ C. 1051-5.
258. Sause W. T., Cooper J. S., Rush S., Ago C. T., Cosmatos D., Coughlin C. T., JanJan N., Lipsett J. Fraction size in external beam radiation therapy in the treatment of melanoma // Int J Radiat Oncol Biol Phys. ‒ 1991. ‒ T. 20, № 3. ‒ C. 429-32.
259. Testori A., Soteldo J., Powell B., Sales F., Borgognoni L., Rutkowski P., Lejeune F., van Leeuwen P., Eggermont A. Surgical management of melanoma: an EORTC Melanoma Group survey // Ecancermedicalscience. ‒ 2013. ‒ T. 7. ‒ C. 294.
260. Lens M. B., Dawes M., Goodacre T., Newton-Bishop J. A. Elective lymph node dissection in patients with melanoma: systematic review and meta-analysis of randomized controlled trials // Arch Surg. ‒ 2002. ‒ T. 137, № 4. ‒ C. 458-61.
261. Foote M., Burmeister B., Dwyer P., Burmeister E., Lambie D., Allan C., Barbour A., Bayley G., Pullar A., Meakin J., Thomas J., Smithers M. An innovative approach for locally advanced stage III cutaneous melanoma: radiotherapy, followed by nodal dissection // Melanoma Res. ‒ 2012. ‒ T. 22, № 3. ‒ C. 257-62.
262. Testori A., Rutkowski P., Marsden J., Bastholt L., Chiarion-Sileni V., Hauschild A., Eggermont A. M. Surgery and radiotherapy in the treatment of cutaneous melanoma // Ann Oncol. ‒ 2009. ‒ T. 20 Suppl 6, № Suppl 6. ‒ C. vi22-9.
263. Phipps A. R., Godfrey A. M., Durrant K. R., Millard P. R. The effect of immediately preoperative adjuvant radiotherapy in the surgical treatment of primary cutaneous malignant melanoma // Br J Plast Surg. ‒ 1992. ‒ T. 45, № 1. ‒ C. 30-3.
264. Swetter S. M., Johnson D., Albertini M. R., Barker C. A., Bateni S., Baumgartner J., Bhatia S., Bichakjian C., Boland G., Chandra S., Chmielowski B., DiMaio D., Dronca R., Fields R. C., Fleming M. D., Galan A., Guild S., Hyngstrom J., Karakousis G., Kendra K., Kiuru M., Lange J. R., Lanning R., Logan T., Olson D., Olszanski A. J., Ott P. A., Ross M. I., Rothermel L., Salama A. K., Sharma R., Skitzki J., Smith E., Tsai K., Wuthrick E., Xing Y., McMillian N., Espinosa S. NCCN Guidelines(R) Insights: Melanoma: Cutaneous, Version 2.2024 // J Natl Compr Canc Netw. ‒ 2024. ‒ T. 22, № 5. ‒ C. 290-298.
265. Yonick D. V., Ballo R. M., Kahn E., Dahiya M., Yao K., Godellas C., Shoup M., Aranha G. V. Predictors of positive sentinel lymph node in thin melanoma // Am J Surg. ‒ 2011. ‒ T. 201, № 3. ‒ C. 324-7; discussion 327-8.
266. Cascinelli N., Belli F., Santinami M., Fait V., Testori A., Ruka W., Cavaliere R., Mozzillo N., Rossi C. R., MacKie R. M., Nieweg O., Pace M., Kirov K. Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience // Ann Surg Oncol. ‒ 2000. ‒ T. 7, № 6. ‒ C. 469-74.
267. Stoffels I., Dissemond J., Poppel T., Schadendorf D., Klode J. Intraoperative Fluorescence Imaging for Sentinel Lymph Node Detection: Prospective Clinical Trial to Compare the Usefulness of Indocyanine Green vs Technetium Tc 99m for Identification of Sentinel Lymph Nodes // JAMA Surg. ‒ 2015. ‒ T. 150, № 7. ‒ C. 617-23.
268. de Bree E., de Bree R. Implications of the MSLT-1 for sentinel lymph node biopsy in cutaneous head and neck melanoma // Oral Oncol. ‒ 2015. ‒ T. 51, № 7. ‒ C. 629-33.
269. van Akkooi A. C., Eggermont A. M. Melanoma: MSLT-1--SNB is a biomarker, not a therapeutic intervention // Nat Rev Clin Oncol. ‒ 2014. ‒ T. 11, № 5. ‒ C. 248-9.
270. Ross M. I., Gershenwald J. E. How should we view the results of the Multicenter Selective Lymphadenectomy Trial-1 (MSLT-1)? // Ann Surg Oncol. ‒ 2008. ‒ T. 15, № 3. ‒ C. 670-3.
271. Morton D. L. Intraoperative lymphatic mapping and sentinel lymphadenectomy: community standard care or clinical investigation? // Cancer J Sci Am. ‒ 1997. ‒ T. 3, № 6. ‒ C. 328-30.
272. Morton D. L., Cochran A. J., Thompson J. F., Elashoff R., Essner R., Glass E. C., Mozzillo N., Nieweg O. E., Roses D. F., Hoekstra H. J., Karakousis C. P., Reintgen D. S., Coventry B. J., Wang H. J., Multicenter Selective Lymphadenectomy Trial G. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial // Ann Surg. ‒ 2005. ‒ T. 242, № 3. ‒ C. 302-11; discussion 311-3.